A guide to uraemic toxicity
7.4
来源：
Nature
关键字：
computational pathology
发布时间：
2025-09-23 23:34
摘要：
Uraemic retention molecules accumulate in chronic kidney disease and can act as both toxins and potential therapeutic agents. The article emphasizes the importance of understanding these molecules for developing interventions that restore homeostasis. Innovative strategies, including drug therapies and new dialysis technologies, are being explored to mitigate uraemic toxicity and improve patient outcomes.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+重点关注领域符合度
business_impact
0.5分+商业影响力
scientific_rigor
1.5分+数据支撑的科学性
timeliness_innovation
1.5分+时效性与创新性
investment_perspective
2.5分+BOCG投资视角
market_value_relevance
1.0分+市场价值相关性
team_institution_background
0.5分+团队与机构背景
technical_barrier_competition
0.4分+技术壁垒与竞争格局
关键证据
Uraemic retention molecules are key mediators in the pathophysiology of chronic kidney disease.
Identification of uraemic toxin receptors is crucial for developing targeted therapeutic strategies.
Various promising therapeutic approaches to reducing uraemic toxicity are currently being investigated.
真实性检查
否
AI评分总结
Uraemic retention molecules accumulate in chronic kidney disease and can act as both toxins and potential therapeutic agents. The article emphasizes the importance of understanding these molecules for developing interventions that restore homeostasis. Innovative strategies, including drug therapies and new dialysis technologies, are being explored to mitigate uraemic toxicity and improve patient outcomes.